Literature DB >> 34074636

Risk of COVID-19 Disease, Dialysis Unit Attributes, and Infection Control Strategy among London In-Center Hemodialysis Patients.

Ben Caplin1,2, Damien Ashby3, Kieran McCafferty4, Richard Hull5, Elham Asgari6, Martin L Ford7,8, Nicholas Cole9, Marilina Antonelou10,2, Sarah A Blakey3, Vinay Srinivasa4, Dandisonba C B Braide-Azikwe7, Tayeba Roper6, Grace Clark2, Helen Cronin7, Nathan J Hayes11, Bethia Manson2, Alexander Sarnowski5, Richard Corbett3, Kate Bramham7,8, Eirini Lioudaki7,8, Nicola Kumar6, Andrew Frankel3, David Makanjuola9, Claire C Sharpe7,8, Debasish Banerjee5, Alan D Salama10,2.   

Abstract

BACKGROUND AND OBJECTIVES: Patients receiving in-center hemodialysis treatment face unique challenges during the coronavirus disease 2019 (COVID-19) pandemic, specifically the need to attend for treatment that prevents self-isolation. Dialysis unit attributes and isolation strategies that might reduce dialysis center COVID-19 infection rates have not been previously examined. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We explored the role of variables, including community disease burden, dialysis unit attributes (size and layout), and infection control strategies, on rates of COVID-19 among patients receiving in-center hemodialysis in London, United Kingdom, between March 2, 2020 and May 31, 2020. The two outcomes were defined as (1) a positive test for infection or admission with suspected COVID-19 and (2) admission to the hospital with suspected infection. Associations were examined using a discrete time multilevel time-to-event analysis.
RESULTS: Data on 5755 patients dialyzing in 51 units were analyzed; 990 (17%) tested positive and 465 (8%) were admitted with suspected COVID-19 between March 2 and May 31, 2020. Outcomes were associated with age, diabetes, local community COVID-19 rates, and dialysis unit size. A greater number of available side rooms and the introduction of mask policies for asymptomatic patients were inversely associated with outcomes. No association was seen with sex, ethnicity, or deprivation indices, nor with any of the different isolation strategies.
CONCLUSIONS: Rates of COVID-19 in the in-center hemodialysis population relate to individual factors, underlying community transmission, unit size, and layout.
Copyright © 2021 by the American Society of Nephrology.

Entities:  

Keywords:  COVID-19; hemodialysis; infection control

Mesh:

Year:  2021        PMID: 34074636      PMCID: PMC8455047          DOI: 10.2215/CJN.03180321

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   10.614


  12 in total

1.  Clinical Characteristics of and Medical Interventions for COVID-19 in Hemodialysis Patients in Wuhan, China.

Authors:  Fei Xiong; Hui Tang; Li Liu; Can Tu; Jian-Bo Tian; Chun-Tao Lei; Jing Liu; Jun-Wu Dong; Wen-Li Chen; Xiao-Hui Wang; Dan Luo; Ming Shi; Xiao-Ping Miao; Chun Zhang
Journal:  J Am Soc Nephrol       Date:  2020-05-08       Impact factor: 10.121

2.  Epidemiology of COVID-19 in an Urban Dialysis Center.

Authors:  Richard W Corbett; Sarah Blakey; Dorothea Nitsch; Marina Loucaidou; Adam McLean; Neill Duncan; Damien R Ashby
Journal:  J Am Soc Nephrol       Date:  2020-06-19       Impact factor: 10.121

3.  High Prevalence of Asymptomatic COVID-19 Infection in Hemodialysis Patients Detected Using Serologic Screening.

Authors:  Candice Clarke; Maria Prendecki; Amrita Dhutia; Mahrukh A Ali; Hira Sajjad; Oshini Shivakumar; Liz Lightstone; Peter Kelleher; Matthew C Pickering; David Thomas; Rawya Charif; Megan Griffith; Stephen P McAdoo; Michelle Willicombe
Journal:  J Am Soc Nephrol       Date:  2020-07-30       Impact factor: 10.121

4.  Presentation and Outcomes of Patients with ESKD and COVID-19.

Authors:  Anthony M Valeri; Shelief Y Robbins-Juarez; Jacob S Stevens; Wooin Ahn; Maya K Rao; Jai Radhakrishnan; Ali G Gharavi; Sumit Mohan; S Ali Husain
Journal:  J Am Soc Nephrol       Date:  2020-05-28       Impact factor: 10.121

5.  Two metres or one: what is the evidence for physical distancing in covid-19?

Authors:  Nicholas R Jones; Zeshan U Qureshi; Robert J Temple; Jessica P J Larwood; Trisha Greenhalgh; Lydia Bourouiba
Journal:  BMJ       Date:  2020-08-25

6.  A Tutorial on Multilevel Survival Analysis: Methods, Models and Applications.

Authors:  Peter C Austin
Journal:  Int Stat Rev       Date:  2017-03-24       Impact factor: 2.217

7.  Low incidence of SARS-CoV-2, risk factors of mortality and the course of illness in the French national cohort of dialysis patients.

Authors:  Cécile Couchoud; Florian Bayer; Carole Ayav; Clémence Béchade; Philippe Brunet; François Chantrel; Luc Frimat; Roula Galland; Maryvonne Hourmant; Emmanuelle Laurain; Thierry Lobbedez; Lucile Mercadal; Olivier Moranne
Journal:  Kidney Int       Date:  2020-08-25       Impact factor: 10.612

8.  Factors associated with COVID-19-related death using OpenSAFELY.

Authors:  Elizabeth J Williamson; Alex J Walker; Krishnan Bhaskaran; Seb Bacon; Chris Bates; Caroline E Morton; Helen J Curtis; Amir Mehrkar; David Evans; Peter Inglesby; Jonathan Cockburn; Helen I McDonald; Brian MacKenna; Laurie Tomlinson; Ian J Douglas; Christopher T Rentsch; Rohini Mathur; Angel Y S Wong; Richard Grieve; David Harrison; Harriet Forbes; Anna Schultze; Richard Croker; John Parry; Frank Hester; Sam Harper; Rafael Perera; Stephen J W Evans; Liam Smeeth; Ben Goldacre
Journal:  Nature       Date:  2020-07-08       Impact factor: 49.962

9.  Risk Factors for Hospitalization, Mechanical Ventilation, or Death Among 10 131 US Veterans With SARS-CoV-2 Infection.

Authors:  George N Ioannou; Emily Locke; Pamela Green; Kristin Berry; Ann M O'Hare; Javeed A Shah; Kristina Crothers; McKenna C Eastment; Jason A Dominitz; Vincent S Fan
Journal:  JAMA Netw Open       Date:  2020-09-01

10.  Impact of first-wave COronaVIrus disease 2019 infection in patients on haemoDIALysis in Alsace: the observational COVIDIAL study.

Authors:  Nicolas Keller; François Chantrel; Thierry Krummel; Dorothée Bazin-Kara; Anne Laure Faller; Clotilde Muller; Thimothée Nussbaumer; Manfred Ismer; Abdellatif Benmoussa; Mohamed Brahim-Bouna; Stéphanie Beier; Peggy Perrin; Theirry Hannedouche
Journal:  Nephrol Dial Transplant       Date:  2020-08-01       Impact factor: 5.992

View more
  14 in total

1.  Severity of COVID-19 after Vaccination among Hemodialysis Patients: An Observational Cohort Study.

Authors:  Damien R Ashby; Ben Caplin; Richard W Corbett; Elham Asgari; Nicola Kumar; Alexander Sarnowski; Richard Hull; David Makanjuola; Nicholas Cole; Jian Chen; Sofia Nyberg; Kieran McCafferty; Faryal Zaman; Hugh Cairns; Claire Sharpe; Kate Bramham; Reza Motallebzadeh; Kashif Jamil Anwari; Alan D Salama; Debasish Banerjee
Journal:  Clin J Am Soc Nephrol       Date:  2022-06       Impact factor: 10.614

2.  Risk factors associated with COVID-19 severity among patients on maintenance haemodialysis: a retrospective multicentre cross-sectional study in the UK.

Authors:  Haresh Selvaskandan; Katherine L Hull; Sherna Adenwalla; Safa Ahmed; Maria-Cristina Cusu; Matthew Graham-Brown; Laura Gray; Matt Hall; Rizwan Hamer; Ammar Kanbar; Hemali Kanji; Mark Lambie; Han Sean Lee; Khalid Mahdi; Rupert Major; James F Medcalf; Sushiladevi Natarajan; Boavojuvie Oseya; Stephanie Stringer; Matthew Tabinor; James Burton
Journal:  BMJ Open       Date:  2022-05-30       Impact factor: 3.006

3.  Outcome and effect of vaccination in SARS-CoV-2 Omicron infection in hemodialysis patients: a cohort study.

Authors:  Damien R Ashby; Ben Caplin; Richard W Corbett; Elham Asgari; Nicola Kumar; Alexander Sarnowski; Richard Hull; David Makanjuola; Nicholas Cole; Jian Chen; Sofia Nyberg; Suzanne Forbes; Kieran McCafferty; Faryal Zaman; Hugh Cairns; Claire Sharpe; Kate Bramham; Reza Motallebzadeh; Kashif Anwari; Tayeba Roper; Alan D Salama; Debasish Banerjee
Journal:  Nephrol Dial Transplant       Date:  2022-09-22       Impact factor: 7.186

4.  Keeping Dialysis Patients Safe.

Authors:  Roberta L Wager
Journal:  Clin J Am Soc Nephrol       Date:  2021-08-04       Impact factor: 10.614

5.  Evidence-Based Practices to Reduce COVID-19 Transmission in Dialysis Facilities.

Authors:  Alan S Kliger; Renee Garrick
Journal:  Clin J Am Soc Nephrol       Date:  2021-08-04       Impact factor: 10.614

6.  COVID-19 Risk Factors and Mortality Outcomes Among Medicare Patients Receiving Long-term Dialysis.

Authors:  Stephen Salerno; Joseph M Messana; Garrett W Gremel; Claudia Dahlerus; Richard A Hirth; Peisong Han; Jonathan H Segal; Tao Xu; Dan Shaffer; Amy Jiao; Jeremiah Simon; Lan Tong; Karen Wisniewski; Tammie Nahra; Robin Padilla; Kathryn Sleeman; Tempie Shearon; Sandra Callard; Alexander Yaldo; Lisa Borowicz; Wilfred Agbenyikey; Golden M Horton; Jesse Roach; Yi Li
Journal:  JAMA Netw Open       Date:  2021-11-01

7.  Infection control measures to prevent outbreaks of COVID-19 in Quebec hemodialysis units: a cross-sectional survey.

Authors:  William Beaubien-Souligny; Annie-Claire Nadeau-Fredette; Marie-Noel Nguyen; Norka Rios; Marie-Line Caron; Alexander Tom; Rita S Suri Md
Journal:  CMAJ Open       Date:  2021-12-21

Review 8.  COVID-19 and kidney disease: insights from epidemiology to inform clinical practice.

Authors:  Viyaasan Mahalingasivam; Guobin Su; Masao Iwagami; Mogamat Razeen Davids; James B Wetmore; Dorothea Nitsch
Journal:  Nat Rev Nephrol       Date:  2022-04-13       Impact factor: 42.439

9.  Analysis of Experiences in Preventing COVID-19 in Hemodialysis Centers of the North of Poland before the Era of Vaccination.

Authors:  Bogdan Biedunkiewicz; Leszek Tylicki; Ewelina Puchalska-Reglińska; Alicja Dębska-Ślizień
Journal:  Int J Environ Res Public Health       Date:  2022-01-07       Impact factor: 3.390

10.  The Global Impact of the COVID-19 Pandemic on In-Center Hemodialysis Services: An ISN-Dialysis Outcomes Practice Patterns Study Survey.

Authors:  Ryan Aylward; Brian Bieber; Murilo Guedes; Ronald Pisoni; Elliot Koranteng Tannor; Gavin Dreyer; Adrian Liew; Valerie Luyckx; Dibya Singh Shah; Chimota Phiri; Rhys Evans; Rehab Albakr; Jeffrey Perl; Vivekanand Jha; Roberto Pecoits-Filho; Bruce Robinson; Fergus J Caskey
Journal:  Kidney Int Rep       Date:  2021-12-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.